TRCT
LIAN

Tower Research Capital (TRC)’s LianBio American Depositary Shares LIAN Stock Holding History

Tower Research Capital (TRC)’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-878
Closed -$2K – 6363
2023
Q2 		$2K Buy
+878
New +$2.02K ﹤0.01% 5276
2023
Q1 		– Sell
-8,519
Closed -$14K – 6489
2022
Q4 		$14K Sell
8,519
-12,254
-59% -$19.1K ﹤0.01% 3556
2022
Q3 		$41K Buy
20,773
+19,616
+1,695% +$46.9K ﹤0.01% 3340
2022
Q2 		$3K Sell
1,157
-4,746
-80% -$16.1K ﹤0.01% 5440
2022
Q1 		$22K Buy
+5,903
New +$24.4K ﹤0.01% 3462

Other funds holding LIAN

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Tower Research Capital (TRC)'s LIAN Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of LianBio American Depositary Shares (LIAN) in Q3 2023, closing a stake of 878 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in LIAN in Q1 2022 and held it in 5 quarters. The position peaked at $41K in Q3 2022. 38 funds tracked by Wall St. Rank hold LIAN as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining LianBio American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 878 LianBio American Depositary Shares shares in Q3 2023, an estimated $2K.
  • Tower Research Capital (TRC) first reported a position in LianBio American Depositary Shares in Q1 2022 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s LianBio American Depositary Shares position peaked at $41K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.